Gene of the month: HGF

被引:45
作者
Fajardo-Puerta, Ana Belen [1 ]
Prado, Mireia Mato [2 ]
Frampton, Adam E. [1 ,2 ]
Jiao, Long R. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, HPB Surg Unit, Hammersmith Hosp Campus,Du Cane Rd, London W12 0HS, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0HS, England
关键词
HEPATOCYTE GROWTH-FACTOR; FACTOR SCATTER FACTOR; C-MET PROTOONCOGENE; EPITHELIAL MORPHOGENESIS DOWNSTREAM; RECEPTOR TYROSINE KINASE; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; COLORECTAL-CANCER; SIGNALING PATHWAY; EXPRESSION;
D O I
10.1136/jclinpath-2015-203575
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hepatocyte growth factor (HGF) is a multifunctional cytokine with important roles in cell proliferation, survival, motility and morphogenesis. Secreted by cells of mesenchymal origin, HGF is the specific ligand for the tyrosine-kinase receptor c-MET (cellular mesenchymal-epithelial transition), also called MET, which is expressed in different types of epithelial, endothelial and haematopoietic progenitor cells. The HGF/MET axis is involved in several biological processes, such as embryogenesis, organogenesis, adult tissue regeneration (including wound healing and liver regeneration) and carcinogenesis, for both solid and haematological malignancies. 1 2 HGF and its particular interaction with the MET receptor have been extensively investigated in the last decades and remain the focus of numerous clinical trials. 3-8 This short review focuses on HGF structure and function, as well as its roles in liver regeneration and different types of tumours.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 94 条
  • [1] [Anonymous], 2012, Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012
  • [2] Targeted treatments in colorectal cancer: state of the art and future perspectives
    Arnold, Dirk
    Seufferlein, Thomas
    [J]. GUT, 2010, 59 (06) : 838 - 858
  • [3] Met endosomal signalling: In the right place, at the right time
    Barrow-McGee, Rachel
    Kermorgant, Stephanie
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 49 : 69 - 74
  • [4] Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
    Boccaccio, C
    Andò, M
    Tamagnone, L
    Bardelli, A
    Michieli, P
    Battistini, C
    Comoglio, PM
    [J]. NATURE, 1998, 391 (6664) : 285 - 288
  • [5] The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
    Boissinot, Marjorie
    Vilaine, Mathias
    Hermouet, Sylvie
    [J]. CANCERS, 2014, 6 (03): : 1631 - 1669
  • [6] BOIX L, 1994, HEPATOLOGY, V19, P88, DOI 10.1002/hep.1840190115
  • [7] IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT
    BOTTARO, DP
    RUBIN, JS
    FALETTO, DL
    CHAN, AML
    KMIECIK, TE
    VANDEWOUDE, GF
    AARONSON, SA
    [J]. SCIENCE, 1991, 251 (4995) : 802 - 804
  • [8] Targeting the HGF/Met signaling pathway in cancer therapy
    Cecchi, Fabiola
    Rabe, Danie C.
    Bottaro, Donald P.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (06) : 553 - 572
  • [9] The genomic landscape of oesophagogastric junctional adenocarcinoma
    Chong, Irene Y.
    Cunningham, David
    Barber, Louise J.
    Campbell, James
    Chen, Lina
    Kozarewa, Iwanka
    Fenwick, Kerry
    Assiotis, Ioannis
    Guettler, Sebastian
    Garcia-Murillas, Isaac
    Awan, Saima
    Lambros, Maryou
    Starling, Naureen
    Wotherspoon, Andrew
    Stamp, Gordon
    Gonzalez-de-Castro, David
    Benson, Martin
    Chau, Ian
    Hulkki, Sanna
    Nohadani, Mahrokh
    Eltahir, Zakaria
    Lemnrau, Alina
    Orr, Nicholas
    Rao, Sheela
    Lord, Christopher J.
    Ashworth, Alan
    [J]. JOURNAL OF PATHOLOGY, 2013, 231 (03) : 301 - 310
  • [10] Drug development of MET inhibitors: targeting oncogene addiction and expedience
    Comoglio, Paolo M.
    Giordano, Silvia
    Trusolino, Livio
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) : 504 - 516